Antibody Drug Conjugates Congress
Date: 18/06/2014 to 19/06/2014
Glythera Technical Director Jenny Thirlway will attend the Antibody Drug Conjugates congress on 18 & 19 June 2014 at the Crowne Plaza Barcelona Fira Center, Spain.
With ADCs estimated to be worth $9 Billion in the next 10 years, never has it been so important to develop effective production platforms and highly targeted products to ensure a niche product in an increasingly competitive market. So this congress will offers a highly technical, yet strategic conference addressing the industry's most pressing development and production questions in ADCs an bioconjugation, including ADC design, novel linker technology, alternative payloads, alternative carriers, successful preclinical and clinical development, regulatory insight, and characterisation and manufacturing approaches.
Please find more information at http://www.informa-ls.com/event/adc2014